Statistics
Publications
2
Citations
29
H-Index
2
Active since
2021
Affiliations
Gilead Sciences (United States)(Current)
Ilean Chai is an author at Gilead Sciences (United States) specializing in programmed death-ligand 1 signaling, cancer immunology, and checkpoint inhibitor therapy.
Publications per year
2021–2022
2
2
1–2 of 2